prolaio eVO2peak Module vs Viz AAA

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Prolaio
VS
by Viz.ai

AI Verdict

Tool A, the Prolaio eVO2peak Module, focuses on estimating peak oxygen consumption from wearable sensor data for cardiovascular assessment and research. In contrast, Tool B, Viz AAA, specializes in the AI-powered detection and triage of suspected Abdominal Aortic Aneurysm from CT angiography scans. While both contribute to cardiovascular care, their distinct methodologies and clinical applications make them suitable for different use cases within the broader cardiology domain.

Choose prolaio eVO2peak Module if…

Choose Prolaio eVO2peak Module if your primary goal is to longitudinally monitor and assess a patient's cardiovascular functional capacity using real-world data from wearable sensors. This tool is ideal for clinicians and researchers focused on understanding changes in peak oxygen consumption over time, aiding in the evaluation of cardiovascular health and rehabilitation progress.

View prolaio eVO2peak Module →

Choose Viz AAA if…

Choose Viz AAA if your priority is the rapid, AI-powered detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans to accelerate critical care coordination. This solution is best suited for emergency departments and vascular surgery teams needing immediate alerts and streamlined communication for time-sensitive aortic pathologies.

View Viz AAA →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature prolaio eVO2peak Module Viz AAA
Pricing Unknown Enterprise (hospital/health system)
Deployment Cloud Cloud-based, integrates with PACS and EHR systems.
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Viz AAA

Viz AAA emphasizes seamless integration into existing hospital workflows, real-time alerts, and a HIPAA-compliant communication platform for multidisciplinary teams. It also offers mobile access to imaging and patient information, which are critical for usability in acute care settings. Prolaio eVO2peak Module, while cloud-based and offering a patient-facing app, does not detail the same level of deep clinical workflow integration.

Clinical Value

Viz AAA

Viz AAA provides rapid detection and triage of suspected Abdominal Aortic Aneurysm (AAA), a life-threatening condition, directly accelerating diagnosis and treatment decisions. This direct impact on acute, time-sensitive interventions offers a high and immediate clinical value. Prolaio eVO2peak Module, while valuable for estimating peak oxygen consumption for cardiovascular assessment and research, serves as an 'adjunctive aid' in clinical evaluation for more long-term monitoring.

Pricing & Value

Tie

Both tools lack public pricing transparency, requiring direct contact for specific quotes. While Viz AAA provides a slightly more detailed model (subscription based on algorithms and population served), neither offers enough information to definitively assess overall pricing or value without specific cost data and ROI studies for comparison.

Enterprise Readiness

Viz AAA

Viz AAA demonstrates superior enterprise readiness through explicit integration with existing hospital workflows, PACS, and EHR systems. Furthermore, Viz.ai boasts extensive security certifications including SOC 2 Type II and multiple ISO standards (e.g., 27001, 27701, 27799), and is deployed in nearly 2,000 hospitals, indicating a robust and scalable solution for large healthcare systems.

Innovation

Viz AAA

Viz AAA is recognized as the 'first FDA-cleared AI-powered solution' for the detection and triage of suspected Abdominal Aortic Aneurysm, addressing a critical and acute medical need with a novel AI application. This 'first-to-market' FDA clearance for a life-saving application, coupled with Viz.ai's broader platform innovations like Viz Agent Studio, gives it an edge in innovation. Prolaio eVO2peak Module is innovative in its use of deep learning with wearable data for physiological measurement, but does not claim a similar 'first' in its category.

Support & Docs

Viz AAA

Viz AAA, through Viz.ai, offers a comprehensive support infrastructure including a dedicated customer success team with clinical and workflow specialists, customer success managers, and clinical research scientists. They also provide a support center, help center, customer resources, and a training academy. Prolaio eVO2peak Module does not have publicly detailed information regarding its customer support channels or documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature prolaio eVO2peak Module Viz AAA
Tool Name prolaio eVO2peak Module Viz AAA
Company Prolaio Viz.ai
Tagline Heart care, connected. AI-powered disease detection and intelligent care coordination.
Description Prolaio is a clinical intelligence company that develops FDA-cleared software, such as the eVO2peak Module, to estimate peak oxygen consumption using real-world patient data for cardiovascular research and care. Viz AAA is the first FDA-cleared AI-powered solution by Viz.ai for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans, designed to accelerate diagnosis and care coordination.
Categories Cardiology AI, Clinical Decision Support & Reference Cardiology AI, Radiology & Imaging AI, Triage & ER/ICU AI
Specialties Cardiology, Physical Medicine & Rehab, Sports Medicine Emergency Medicine, Radiology, Vascular Surgery

Videos

Demos, reviews, and walkthroughs featuring prolaio eVO2peak Module and Viz AAA.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Prolaio eVO2peak Module estimates peak oxygen consumption (eVO2peak) using real-world patient data for cardiovascular research and care, serving as an adjunctive aid in clinical evaluation. Viz AAA is an AI-powered solution designed for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans, aiming to accelerate diagnosis and care coordination.
The Prolaio eVO2peak Module utilizes demographic data, single-lead ECG, and triaxial accelerometry inputs, processing data from qualified third-party FDA-cleared wearable medical sensors. Viz AAA analyzes CT angiography scans of the abdomen to detect suspected AAA.
Prolaio eVO2peak Module provides an estimation of peak oxygen consumption (eVO2peak) as an adjunctive aid in clinical evaluation, enabling high-density, longitudinal data collection. Viz AAA offers AI-powered automatic detection of suspected AAA from CTA scans, automated triage and prioritization of cases, real-time alerts to care teams, and mobile access to high-fidelity imaging and patient information.
The Prolaio eVO2peak Module is designed for Cardiology, Physical Medicine & Rehab, and Sports Medicine. Viz AAA primarily supports Emergency Medicine, Radiology, and Vascular Surgery.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.